<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>GLP-1 Quiz</title>
    <style>
      :root {
        --bg: #ffffff;
        --card: #ffffff;
        --text: #2c3e50;
        --accent: #f2c35c;
        --button: #5549ff;
        --button-shadow: rgba(25, 85, 70, 0.25);
        --line: #d3d3d3;
        --shadow: rgba(15, 23, 42, 0.12);
      }

      * {
        box-sizing: border-box;
      }

      body {
        margin: 0;
        min-height: 100vh;
        font-family: "Lato", "Open Sans", "Helvetica Neue", Arial, sans-serif;
        background: var(--bg);
        color: var(--text);
        display: flex;
        align-items: center;
        justify-content: center;
        padding: 48px 20px;
        position: relative;
        overflow: hidden;
      }

      .background-shapes {
        position: absolute;
        inset: 0;
        pointer-events: none;
      }

      .shape {
        position: absolute;
      }

      .shape.circle-outline {
        width: 22px;
        height: 22px;
        border: 2px solid #000000;
        border-radius: 50%;
        top: 40px;
        left: 60px;
      }

      .shape.circle-solid {
        width: 10px;
        height: 10px;
        background: #000000;
        border-radius: 50%;
        bottom: 70px;
        right: 70px;
      }

      .shape.cross {
        width: 16px;
        height: 16px;
        top: 90px;
        left: 120px;
      }

      .shape.cross::before,
      .shape.cross::after {
        content: "";
        position: absolute;
        top: 50%;
        left: 50%;
        width: 16px;
        height: 2px;
        background: #000000;
        transform: translate(-50%, -50%) rotate(45deg);
      }

      .shape.cross::after {
        transform: translate(-50%, -50%) rotate(-45deg);
      }

      .shape.cross.second {
        top: 140px;
        left: 200px;
      }

      .shape.triangle {
        width: 0;
        height: 0;
        border-left: 16px solid transparent;
        border-right: 16px solid transparent;
        border-bottom: 28px solid #f7b7a0;
        top: 60px;
        right: 80px;
      }

      .shape.triangle.small {
        border-left-width: 10px;
        border-right-width: 10px;
        border-bottom-width: 18px;
        bottom: 60px;
        right: 110px;
      }

      .shape.poly-purple {
        width: 44px;
        height: 30px;
        background: #6a5acd;
        border-radius: 6px;
        transform: skew(-10deg, -8deg);
        top: 110px;
        left: 260px;
      }

      .shape.poly-dark {
        width: 54px;
        height: 38px;
        background: #483d8b;
        border-radius: 10px 6px 12px 8px;
        transform: skew(8deg, -6deg);
        bottom: 90px;
        left: 70px;
      }

      .shape.zigzag {
        width: 46px;
        height: 46px;
        border: 2px solid #1f2933;
        border-radius: 6px;
        transform: rotate(10deg) skew(-10deg, 0deg);
        bottom: 110px;
        right: 180px;
        clip-path: polygon(0% 10%, 45% 10%, 60% 0%, 75% 10%, 100% 10%, 100% 90%, 55% 90%, 40% 100%, 25% 90%, 0% 90%);
      }

      .card {
        width: min(640px, 92vw);
        background: var(--card);
        border-radius: 24px;
        box-shadow: 0 18px 45px var(--shadow);
        padding: 50px 48px 44px;
        text-align: center;
        position: relative;
        z-index: 1;
      }

      .headline {
        font-size: clamp(1.7rem, 1.2rem + 2vw, 2.2rem);
        font-weight: 700;
        line-height: 1.35;
        margin: 0 0 28px;
        display: flex;
        flex-wrap: wrap;
        align-items: center;
        justify-content: center;
        gap: 8px;
      }

      .headline span {
        display: inline-flex;
        align-items: center;
      }

      .starburst {
        width: 14px;
        height: 14px;
        display: inline-block;
        background: var(--accent);
        clip-path: polygon(50% 0%, 60% 40%, 100% 50%, 60% 60%, 50% 100%, 40% 60%, 0% 50%, 40% 40%);
        margin: 0 8px;
      }

      .cta {
        display: inline-block;
        background: var(--button);
        color: #ffffff;
        border: none;
        border-radius: 999px;
        padding: 16px 40px;
        font-size: 1rem;
        font-weight: 600;
        box-shadow: 0 12px 20px var(--button-shadow);
        text-decoration: none;
      }

      .disclaimer {
        margin: 28px auto 0;
        font-size: 0.5rem;
        line-height: 1.5;
        color: #4b5563;
      }

      .disclaimer p {
        margin: 0 0 16px;
      }

      @media (max-width: 600px) {
        .card {
          padding: 40px 28px 36px;
        }

        .headline {
          gap: 6px;
        }

        .disclaimer {
          font-size: 0.4rem;
        }

        .shape.poly-purple {
          left: 200px;
        }
      }
    </style>
  </head>
  <body>
    <div class="background-shapes" aria-hidden="true">
      <span class="shape circle-outline"></span>
      <span class="shape cross"></span>
      <span class="shape poly-purple"></span>
      <span class="shape cross second"></span>
      <span class="shape triangle"></span>
      <span class="shape poly-dark"></span>
      <span class="shape zigzag"></span>
      <span class="shape circle-solid"></span>
      <span class="shape triangle small"></span>
    </div>

    <main class="card">
      <h1 class="headline">
        <span><span class="starburst"></span>Get pre-approved
        for weight loss medication with our 3 minute online
        assessment<span class="starburst"></span>
      </h1>
      <a
        class="cta"
        href="https://afflat3e1.com/trk/lnk/B1AD5CBC-6067-422F-B701-BBCB91E47D47/?o=30881&c=918277&a=714640&k=7D7BF71E4AE0F16B86871A3DC30D038E&l=36115"
      >
        Take Assessment
      </a>
      <div class="disclaimer">
        <p>
          Side effects of Wegovy (R) may include possible thyroid tumors. See
          here for details.
        </p>
        <p>
          *In a multi-national, double-blind clinical trial of over 17,000
          patients with BMI of 27 or greater, weekly injections of semaglutide
          for a mean duration of 33 months reduced the risk of a composite of
          death from cardiovascular causes, nonfatal myocardial infarction, or
          nonfatal stroke by 20%. Lincoff AM, Brown-Frandsen K, Colhoun HM, et
          al. Semaglutide and Cardiovascular Outcomes in Obesity without
          Diabetes. N Engl J Med. 2023;389(24):2221-2232.
          doi:10.1056/NEJMoa2307563.
        </p>
      </div>
    </main>
  </body>
</html>
